Ibrutinib therapy in patients with relapsed/refractory marginal zone lymphoma: Analysis by prior rituximab treatment and baseline mutations Meeting Abstract
| Authors: | Chen, R.; de Vos, S.; Thieblemont, C.; Martin, P.; Flowers, C.; Morschhauser, F.; Collins, G.; Ma, S.; Coleman, M.; Peles, S.; Smith, S. D.; Barrientos, J. C.; Smith, A.; Munneke, B.; Wu, S.; Cheung, L.; Kwei, K.; Samakoglu, S.; Arango-Hisijara, I.; Dimery, I.; Noy, A. |
| Abstract Title: | Ibrutinib therapy in patients with relapsed/refractory marginal zone lymphoma: Analysis by prior rituximab treatment and baseline mutations |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419700226 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.3026.3026 |
| Notes: | Meeting Abstract: 3026 -- Source: Wos |
